Difference between revisions of "Meningioma"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1425")
Line 23: Line 23:
  
 
==[https://www.nccn.org/ NCCN]==
 
==[https://www.nccn.org/ NCCN]==
*''NCCN does not currently have guidelines at this granular level; please see [https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf NCCN Guidelines - Central Nervous System Cancers].''
+
*''NCCN does not currently have guidelines at this granular level; please see [https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1425 NCCN Guidelines - Central Nervous System Cancers].''
  
 
[[Category:Meningioma regimens]]
 
[[Category:Meningioma regimens]]
 
[[Category:Disease-specific pages]]
 
[[Category:Disease-specific pages]]
 
[[Category:CNS cancers]]
 
[[Category:CNS cancers]]

Revision as of 18:05, 6 May 2024

Section editor
SeemaNagpal.jpg
Seema Nagpal, MD
Stanford University
Palo Alto, CA, USA

LinkedIn

Are you looking for a regimen but can't find it here? For placebo or observational studies in this condition, please visit this page. If you still can't find it, please let us know so we can add it!

0 regimens on this page
0 variants on this page


Guidelines

Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.

EANO

ISRS

NCCN